OBJECTIVES: CD44 comprises a family of isoforms involved in tumorigenesis. Here we investigate the role of CD44 isoforms in head and neck squamous cell carcinoma (HNSCC) progression.
MATERIALS AND METHODS: HNSCC specimens underwent reverse transcriptase-polymerase chain reaction (RT-PCR) followed by Southern blot analysis. After surface biotinylation, FaDu (hypopharyngeal HNSCC) and CD44v3-transfected COS-7 cells were CD44 antibody-precipitated and compared by Western blot analysis. FaDu cells underwent double immunofluorescence staining and growth assays.
RESULTS: Southern blot analysis suggested differential CD44v3 isoform expression in tumor and normal tissue. Cloning and sequencing revealed 2 novel CD44v isoforms. Western blot analysis suggested CD44v3 expression in COS-7 transfectants and FaDu. Double immunofluorescence staining revealed colocalization of CD44v3 and actin in FaDu projections. Anti-CD44v3 antibody decreased FaDu growth.
CONCLUSION: HNSCC tissue and FaDu appear to express CD44v3 isoforms. These isoforms may promote tumorigenesis.
CLINICAL SIGNIFICANCE: CD44v3 isoforms may be effective tumor markers and targets for HNSCC therapy.
Get full access to this article
View all access options for this article.
References
1.
SlaughterDPSouthwickHWSmejkalW.“Field cancerization” in oral stratified squamous epithelium clinical implications of multicentric origin. Cancer1953; 3:963–8.
2.
PapadimitrakopoulouVAShinDMHongWKMolecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorgenesis. Cancer Metastasis Rev1996; 15:53–76.
3.
BourguignonLYLokeshwarVAHeJ, et al. A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin. Mol Cell Biol1992; 12:4464–71.
4.
BrownTABouchardTSt.JohnT, et al. Human keratinocytes express a new CD44 core protein (CD44E) as a heparin-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol1991; 113:207–21.
5.
OmaryMBTrowbridgeISLetarteM, et al. Structural heterogeneity of human Pgp-1 and its relationship with p85. Immunogenetics1988; 27:460–4.
6.
TrowbridgeISLesleyJSchulteR, et al. Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues. Immunogenetics1982; 15:299–312.
7.
BourguignonLYWIidaNWelshCF, et al. Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion, and tumor metastasis. J Neurooncol1995; 26:201–8.
8.
GunthertU.CD44: A multitude of isoforms with diverse functions. Curr Top Microbiol Immunol1993; 184:47–63.
9.
ScreatonGRBellMVJacksonDG, et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA1992; 89:12160–4.
10.
LokeshwarVBBourguignonLYWPost-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis. J Biol Chem1991; 266:17983–9.
11.
JacksonDGBellJIDickinsonR, et al. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol1995; 128:673–85.
12.
IidaNBourguignonLYWNew CD44 splice variants associated with human breast cancers. J Cell Physiol1995; 162:127–33.
13.
LokeshwarVBIidaNBourguignonLYWThe cell adhesion molecule, GP116, is a new CD44 variant (ex14/v10) involved in hyaluronic acid binding and endothelial cell proliferation. J Biol Chem1996; 271:23853–64.
14.
BourguignonLYWInteractions between the membrane-cytoskeleton and CD44 during lymphocyte signal transduction and cell adhesion. Curr Topics Membr1996; 43:293–312.
15.
BourguignonLYWZhuDZhuH.CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression. Front Biosci1998; 3:637–49.
16.
BennettKLJacksonDGSimonJC, et al. CD44 isoforms containing exon v3 are responsible for the presentation of heparinbinding growth factor. J Cell Biol1995; 128:687–98.
17.
KalishEDIidaNMoffatFL, et al. A new CD44v3-containing isoform is involved in tumor cell growth and migration during human breast carcinoma progression. Front Biosci1999; 4:1–8.
18.
BourguignonLYWGunja-SmithZIidaN, et al. CD44v3,8-10 is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol1998; 176:206–15.
19.
BourguignonLYWZhuHShaoL, et al. Rho-kinase (ROK) promotes CD44v3,8-10-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motil Cytoskeleton1999; 43:267–87.
20.
BourguignonLYWZhuHShaoL, et al. CD44 interaction with Tiam1 promotes Rac1 signaling and hyaluronic-acid-mediated breast tumor cell migration. J Biol Chem2000; 275:1829–38.
21.
KaufmannMHeiderKHSinnHP, et al. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet1995; 345:615–9.
22.
TempferCSliutzGHaeuslerG, et al. CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer. Br J Cancer1998; 78:1091–4.
23.
ZhuDBourguignonLYWThe ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation. Cell Motil Cytoskelton1998; 39:209–22.
24.
OliveiraDTSherriffMOdellEWExpression of CD44 variant exons by primary and metastatic oral squamous carcinomas. J Oral Pathol Med1998; 27:303–7.
25.
CastellaEArizaAFernandez-VasaloA, et al. Expression of CD44H and CD44v3 in normal oesophagus, Barrett mucosa, and oesophageal carcinoma. J Clin Path1996; 49:489–92.
26.
HudsonDLSpeightPMWattFMAltered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them. Int J Cancer1996; 66:457–63.
27.
SeelentagWKFGunthertUSaremaslaniP, et al. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation. Int J Cancer1996; 69:218–24.
28.
FoxSBFawcettJJacksonD, et al. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res1994; 54:4539–46.
29.
ZhuDBourguignonLYWInteraction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid (HA)-mediated ovarian tumor cell migration. J Cell Physiol2000; 183:182–95.
30.
HashimotoKHigashiyamaSAsadaH, et al. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J Biol Chem1994; 269:20060–6.
